Evidence map›Paper›PMID 38025481›Full record

SynthesisFrontiers in psychiatry2023

Substance use during pregnancy and risk of postpartum depression: a systematic review and meta-analysis.

Malein Pacho, Claudia Aymerich, Borja Pedruzo, Gonzalo Salazar de Pablo, Eva Sesma, Marta Bordenave, Rodrigo Dieguez, Itziar Lopez-Zorroza, Jon Herrero, Maria Laborda and 4 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Cannabis Use during Pregnancy: An Update.Medicina (Kaunas, Lithuania) · 2024
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Malein Pacho *Psychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Claudia Aymerich *Psychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Borja PedruzoPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Gonzalo Salazar de PabloEarly Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Eva SesmaPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Marta BordenavePsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Rodrigo DieguezPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Itziar Lopez-ZorrozaPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Jon HerreroPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Maria LabordaPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Aranzazu Fernandez-RivasPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Clemente Garcia-RizoBarcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, Department of Medicine, Institut de Neurociències, Universitat de Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Miguel Angel Gonzalez-TorresPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Ana CatalanPsychiatry Department, Basurto University Hospital, Osakidetza, Basque Health Service, Bilbao, Spain.
Osakidetza · ESBioCruces Health research Institute · ESHospital de Basurto · ESUniversidad Complutense de Madrid · ESUniversitat de Barcelona · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Postpartum depression (PPD) is a prevalent mental health condition affecting women globally within the first year following childbirth. Substance use during pregnancy has been associated with an increased risk of developing PPD, but the evidence remains inconclusive. This meta-analysis aims to comprehensively assess the effects of different substances on PPD risk, exploring potential modifiers and confounding factors. Objectives: To examine the proportion of PPD among substance users during pregnancy, compared to non-users, and investigate the specific risk associated with different substances (tobacco, alcohol, and non-specified substance use/multiple substance use). Methods: A systematic literature search was conducted from inception to November 2022 using the Web of Science database (Clarivate Analytics), incorporating Web of Science Core Collection, the BIOSIS Citation Index, the KCI-Korean Journal Database, MEDLINE Results: Among the 26 included studies, encompassing 514,441 women, the pooled prevalence of PPD among substance users during pregnancy was 29% (95% CI 25-33). Meta-analyzes revealed an overall odds ratio (OR) of 3.67 (95% CI 2.31-5.85, Conclusion: This meta-analysis provides evidence of an increased risk of PPD among pregnant substance users, particularly those using multiple substances or tobacco. However, caution is needed in interpreting the association with alcohol use due to its non-significant result. Systematic review registration: This study protocol was registered at PROSPERO (registration number: CCRD42022375500).

Indexed as

alcohol use disorderperinatalpostpartumpostpartum depressionsubstance use disordertobacco

Identifiers

PMID38025481
PMCPMC10666188
OpenAlexW4388636272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.